1991
DOI: 10.1016/0031-9384(91)90490-f
|View full text |Cite
|
Sign up to set email alerts
|

Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
49
0

Year Published

1993
1993
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 132 publications
(51 citation statements)
references
References 23 publications
2
49
0
Order By: Relevance
“…Several studies revealed that the Y1R subtype plays a prominent role in mediating feeding induced by NPY (22,23,47). Because gastric relaxation was also achieved by the Y1R in the present study, this gastric relaxation might be closely associated with food intake.…”
Section: Discussionsupporting
confidence: 64%
See 1 more Smart Citation
“…Several studies revealed that the Y1R subtype plays a prominent role in mediating feeding induced by NPY (22,23,47). Because gastric relaxation was also achieved by the Y1R in the present study, this gastric relaxation might be closely associated with food intake.…”
Section: Discussionsupporting
confidence: 64%
“…Kalra et al (24), citing a large number of studies, described NPY as the only messenger molecule for a physiological appetite transducer in the brain. Several studies revealed that the Y1 receptor subtype (Y1R) is the most prominent factor in mediating feeding induced by NPY (22,23,47). Feeding responses induced by melanin-concentrating hormone was attenuated by the antagonistic effects of Y1R (5).…”
mentioning
confidence: 99%
“…Injection of NPY or NPY-related peptides intracranially (either into the hypothalamus or cerebral ventricles) stimulates robust feeding (1)(2)(3)(4)(5)(6); conditions of energy deprivation (starvation) or increased energy demand (lactation) induce NPY expression in the hypothalamus (7,8); most genetic models of obesity exhibit hyperphagia and an increase in hypothalamic NPY levels (9)(10)(11)(12)(13); and various pharmacological treatments that enhance feeding are accompanied by an increase in NPY (14). In addition, various methods (antisense oligonucleotides, antibodies, or receptor antagonists) aimed at blocking NPY actions in the hypothalamus have been shown to inhibit feeding (15)(16)(17)(18)(19)(20)(21)(22).…”
mentioning
confidence: 99%
“…Structure-function analyses of these peptides' feeding stimulatory effects reveal pharmacological specificity in terms of the amino acid sequence required for efficacy. These studies show the critical amino acid sequence for NPY to be theN-terminalamino acids 1-12 (79,165). For GAL,theyare the first 16 N-terminal amino acids (48).…”
Section: Physiological and Behavioral Effects Of Brain Peptidesmentioning
confidence: 96%